申请人:Sattigeri Jitendra A.
公开号:US20110166088A1
公开(公告)日:2011-07-07
The present invention provides Gyrase B and/or Topoisomerase IV par E inhibitors, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci,
Haemophilus, Pseudomonas
spp.,
Acenetobacter
spp.,
Moraxalla
spp.,
Chlamydia
spp.,
Mycoplasma
spp.,
Legionella
spp.,
Ktycobacterium
spp.,
Helicobacter, Clostridium
spp.,
Bacteroides
spp.,
Corynebacterium, Bacillus
spp., Enterobactericeae,’ (
E. coli, Klebsiella
spp.,
Proteus
spp., etc.) or any combination thereof. Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections. (Formula)